CasLoc logo
All Cases PTAB Litigations UPC Oppositions
The patent has been granted The patent has been granted, Grant of patent is intended, Request for examination was made, The international publication has been made EP Register Verified

HETEROCYCLIC GLP-1 AGONISTS

Publication No. EP4143183
•
App No. EP21795712
•
Filed by Gasherbrum Bio, Inc.
•
Filed on 2021-04-28
•
Issued/Published on 2025-10-22
Publication No. EP4143183 A1
Application No. EP21795712 Filed: 2021-04-28
Grant Date 2025-10-22 Mention of grant
Active Oppositions 1 Active EPO Oppositions

Patent Abstract / Summary

Patent abstract is being processed or was not provided in English by the publishing office.

IPC Classifications

C07D405/14, C07D405/12, C07D413/14, C07D471/04, A61P3/10, A61K31/496, A61K31/4545, A61K31/538 C07D405/14, C07D405/12, C07D413/14, A61P3/10, A61K31/496

Priority Claims

WO 2020CN87776 Date: 2020-04-29
WO 2020CN105865 Date: 2020-07-30

Designated Contracting States (38 EPC States)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

Parties & Representation

Applicants

Gasherbrum Bio, Inc.

611 Gateway Blvd. Suite 223, South San Francisco, California 94080

US

Inventors (4)

JENNINGS, Andrew

San Francisco, California 94121

US

LEI, Hui

Shanghai 201210

CN

LIN, Xichen

Shanghai 201210

CN

MENG, Qinghua

Shanghai 201210

CN

Representatives / Agents

Carpmaels & Ransford LLP

One Southampton Row, London WC1B 5HA

GB

Jones Day

Gewürzmühlstr. 11, 80538 München

DE

Key Procedural Dates

Request-For-Examination 2022-10-31
Mention Of Grant Published 2025-10-22
First-Examination-Report-Despatched 2024-12-02